ICIP Info Session
Wednesday, June 19, 2013 from 8:30 AM to 11:00 AM (EDT)
San Francisco, California
London, United Kingdom
Come participate in the Massachusetts Life Sciences Center’s (MLSC) inaugural round of the International Collaborative Industry Program (ICIP)! The MLSC will partner with Victoria, Australia; the Wallonia region of Belgium; Quebec, Canada; and Alsace in France to award funding to support winning projects demonstrating innovative and collaborative research and development (R&D) in Massachusetts and in the partnering regions. Companies from biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics are eligible to submit collaborative project applications.
An eligible project will be in late-stage R&D, and will consist of one Massachusetts company and one company from one of the four international partner regions. Winning partners emerging from this competitive process will each be funded by an agency in their own geography.
About the International Collaborative Industry Program (ICIP) The MLSC’s International Collaborative Industry Program (ICIP) seeks to promote collaboration and idea exchange between life sciences companies around the world, as well as to stimulate the development of new products or processes intended for commercialization. ICIP accepts project proposals rooted in the life sciences: Biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics. Projects sponsored together by a Massachusetts life sciences company and a company from one of the participating international partner regions are eligible to apply for joint funding from the MLSC and the respective international partner agency.